Positioning time in range in diabetes management
Advani A
Diabetologia. 2020;63:242-52
Leggi
Breaking news
Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial
Fitchett D, Inzucchi SE, Wanner C, et al.
Eur Heart J. 2020;41(2):209-17
Leggi
Autoimmunity plays a role in the onset of diabetes after 40 years of age
Rolandsson O, Hampe CS, Sharp SJ, et al.
Diabetologia. 2020;63:266-77
Leggi
A new perspective on lowering CV risk from hypoglycaemia
Solis-Herrera C, Sheikh O, Chilton R
Eur Heart J. 2020;41(2):218-20
Leggi
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Fleming GA, Petrie JR, Bergenstal RM, et al.
Diabetologia. 2020, 63:229–241
Leggi
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Buse JB, Wexler DJ, Tsapas A, et al.
Diabetologia. 2020;63:221-8
Leggi
Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus
Munshi VN, Saghafian S, Cook CB, et al.
Am J Cardiol. 2020;125(3):436-40
Leggi
Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European observational multicentre study)
Creta A, Providência R, Adragao P, et al.
Am J Cardiol. Pub. online 30 December 2019
Leggi
Incidence, Risk Factors, and Trends for Postheart Transplantation Diabetes Mellitus
Munshi VN, Saghafian S, Cook CB, et al.
Am J Cardiol. 2020;125(3):436-40
Leggi
Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up
Yu Y, Arah OA, Liew Z, et al.
BMJ. 2019;367:l6398
Leggi